PharmaDiagnostics, a developer of label-free screening technology that does not require specialised instrumentation, has appointed Dr Sylviane Boucharens as director of assay development. She joins from Merck’s MSD site in Newhouse, Scotland, where she was head of global compound repository and in vitro screening.
Boucharens will play a central role in driving the growth of PharmaDiagnostics’ assay product range, and in developing business globally. She worked at Merck from 2000 to 2011. She started her career in the pharmaceutical industry in 1995 when she joined the Immunology Department in the Laboratoires Fournier (Dijon, France).
PharmaDiagnostics appoints director of assay development
Former pharma department head joins Belgian firm
You may also like
Manufacturing
![Pharmaceutical company cuts energy use and achieves ISO compliance with compressor and dryer upgrade]()
Pharmaceutical company cuts energy use and achieves ISO compliance with compressor and dryer upgrade
A leading biopharmaceutical manufacturer in England is realising substantial energy savings after upgrading its ageing compressed air system with Atlas Copco’s oil-free VSD+ compressors and the world’s first air-cooled MDG rotary drum desiccant dryer
Manufacturing
![Air, cooling and filtration: The critical utilities behind sterile pharmaceutical production]()
Air, cooling and filtration: The critical utilities behind sterile pharmaceutical production
When pharmaceutical manufacturers discuss quality and compliance, the focus often falls on formulation, inspection and validation of the valuable products they manufacture. Less visible, but equally important, are the utilities that support production
Manufacturing
![40 years of partnership with Huber]()
40 years of partnership with Huber
From research laboratories to pilot plants and full-scale production, Huber systems continue to support critical applications across the chemical, pharmaceutical, biotechnology, aerospace, and process industries with exceptional thermal control performance